ArticleFuture oncology (London, England)2024

Ovarian Cancer Retrospective European (O'CaRE) study: first-line outcomes by number of risk factors for progression.

Jonathan Krell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.